Whi Summary
The Women's Health Initiative (WHI), sponsored by the National Heart, Lung, and Blood Institute (NHLBI), is a long-term national health study that focuses on strategies for preventing heart disease, breast and colorectal cancer, and osteoporosis in postmenopausal women.
What is the women's health Initiative trial?
The Women's Health Initiative (WHI) hormone therapy (HT) trials were designed to determine the benefits and risks of HT taken for chronic disease prevention by predominantly healthy postmenopausal women.
The Women's Health Initiative Hormone Therapy Trials - NCBI
What were the results of the women's health Initiative concerning hormone therapy?
WHI results in 2002 found that post-menopausal women taking combination (estrogen and progestin) hormone therapy for menopause symptoms had an increased risk for breast cancer, heart disease, stroke, blood clots, and urinary incontinence.
Largest women's health prevention study ever
The Women's Health Initiative (WHI) was a series of clinical studies initiated by the U.S. National Institutes of Health (NIH) in 1991, to address major health issues causing morbidity and mortality in postmenopausal women. It consisted of three clinical trials (CT) and an observational study (OS).
Women's Health Initiative - Wikipedia
Why was the WHI study terminated early?
One treatment-arm of the Women's Health Initiative (WHI) study was recently terminated because the overall risks of hormone treatment were considered to outweigh the benefits. The main findings were an increased risk of venous thromboembolism and a decreased risk of osteoporotic fractures with treatment.
[After the early termination of the Women's Health Initiative study ...